Article and Video CATEGORIES
Dr. Mark Socinski covered the TAILOR trial, an Italian study directly comparing second line Taxotere (docetaxel) to Tarceva (erlotinib) in advanced NSCLC patients without an EGFR mutation, in the ASCO Lung Cancer Highlights program. However, as a preview to his comments you'll find in the podcast here, I'll share that he wasn't fond of the trial or the questionable value of the results from it.
Still, the trial is among the ones likely to be most discussed in the field of lung cancer from ASCO 2012, so it's worth hearing what it showed, along with an expert perspective of how to interpret it. Below, you'll find the audio and video versions of the podcast along with the transcript and figures.
Dr. Socinski ASCO LC Highlights 2012 TAILOR Trial Audio Podcast
Dr. Socinski ASCO LC Highlights 2012 TAILOR Trial Transcript
Dr. Socinski ASCO LC Highlights 2012 TAILOR Trial Figs
We'll finish Dr. Socinski's presentation of ASCO Highlights in Lung Cancer with his summary of some work in small cell lung cancer. Look for that soon.
Please feel free to offer comments and raise questions in our
discussion forums.
Forum Discussions
Hi Revtoby, Welcome to Grace. I'm sorry you and your wife are worried about cancer but we couldn't say whether or not your wife's leison is cancer no matter how much...
Canyil, I'm sorry your father and you are going through this. While we can't give urgent help we are her to help offer info and resources to help make the best...
Hello and welcome to Grace. I'm sorry you're going through this worry. It is normal to watch a small very slow-growing solid nodule with once-a-year CT scans. Anything less than a...
Thanks you very much. So in summary the course of action taken suggested by lung specalist (re scan in 12 months) seems appropriate? And a PET at this stage is probably...
I can't say what is appropriate for you that's only something your professionals with all your information can do. However, when someone has a solid nodule less than a cm that...